ArticlePLOS global public health2025
HPV knowledge and non-adherence to cervical cancer screening before and following the COVID-19 pandemic in the United States.
Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Adherence to HPV-Based Cervical Cancer Screening: A Concept Analysis for Nursing and Midwifery Practice.Journal of multidisciplinary healthcare · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To compare HPV vaccination knowledge and non-adherence rates to cervical cancer screening in a nationally representative sample of American women before and following the COVID-19 pandemic, female participants aged 21-65 years from the National Cancer Institute Health Information National Trends Survey 2019 and 2022 were included. Adherence to cervical cancer screening was assessed based on the timing of their last Papanicolaou (PAP) smear, with participants classified as non-adherent to cervical cancer guidelines if their last PAP smear was > 3 years. Further, participants were asked about their knowledge of the HPV vaccine and were categorized as unaware if they had not heard of it before. Survey-weighted Poisson regression models adjusted for age, race, and education were used to explore both adherence and HPV vaccination knowledge before and following the COVID-19 pandemic. We included 1,905 females with a mean age of 44.5 years, 61.3% were White, and 35.4% had a college education or higher. The prevalence of non-adherence in 2019 was 19.2% and increased by 6.6% in 2022. White adults showed an increase of 5.6%, while Black adults showed an increase of 13.9%. When exploring changes in HPV vaccination knowledge, 18.9% did not hear about the HPV vaccine in 2019, which slightly increased by 2.8% in 2022. Being Black and having lower education were significantly associated with both greater non-adherence rates and not hearing about HPV vaccine. Non-adherence to cervical cancer screening increased following the COVID-19 pandemic, especially amongst under-represented communities including Black adults and those with lower education. This trend was also reflected in reduced awareness of HPV vaccination. Further studies are needed to elucidate barriers associated with greater non-adherence rates and to explore targeted interventions, such as educational campaigns, community outreach programs, and initiatives to improve access for underserved populations, which may promote more equitable screening uptake and healthcare access.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.